{"title":"Giant Left Atrium in Triple Rheumatic Heart Disease","authors":"G. Berisha, E. Haliti, Gani Bajraktari","doi":"10.17987/icfj.v13i0.498","DOIUrl":"https://doi.org/10.17987/icfj.v13i0.498","url":null,"abstract":"The giant left atrium (GLA) is a rare condition, commonly associated with rheumatic mitral valve disease, and very rarely with non rheumatic heart disease (nRHD). The triple valvular heart disease with involved mitral, aortic and tricuspid valves is quite uncommon. A 47 year female patient with a past medical history of rheumatic heart disease (RHD) and known severe mitral stenosis was with severe breathlessness (NYHA class IV). She had undergone mitral valve commissurotomy and tricuspid valve annuloplasty 12 years previously. Transthoracic echocardiography revealed a giant left atrium, moderate to severe mitral valve restenosis, severe mitral regurgitation, moderate aortic regurgitation and severe tricuspid regurgitation, associated with severe secondary pulmonary hypertension and a markedly dilated right heart chambers. The patient was considered inoperable by the heart team, because of advanced pulmonary hypertension predicting a very high risk for open heart surgery. The final treatment decision was a difficult and complex issue.","PeriodicalId":32119,"journal":{"name":"International Cardiovascular Forum Journal","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84293699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yuhui Zhao, R. Nicoll, A. Diederichsen, H. Mickley, Kristian A. Øvrehus, P. Zamorano, P. Guéret, A. Schmermund, E. Maffei, Filippo Cademartiri, M. Budoff, M. Henein
{"title":"Coronary Calcification and Male Gender Predict Significant Stenosis in Symptomatic Patients in Northern and Southern Europe and the USA: A Euro-CCAD Study","authors":"Yuhui Zhao, R. Nicoll, A. Diederichsen, H. Mickley, Kristian A. Øvrehus, P. Zamorano, P. Guéret, A. Schmermund, E. Maffei, Filippo Cademartiri, M. Budoff, M. Henein","doi":"10.17987/ICFJ.V13I0.487","DOIUrl":"https://doi.org/10.17987/ICFJ.V13I0.487","url":null,"abstract":"Background and Aims: Significant stenosis is the principal cause of stable angina but its predictors and their variation by geographical region are unclear.Methods and Results: From the European Calcific Coronary Artery Disease (Euro-CCAD) cohort, we retrospectively investigated 5515 symptomatic patients from northern Europe (Denmark, France, Germany), southern Europe (Italy, Spain) and USA. All had conventional cardiovascular risk factor assessment, angiography and CT scanning for coronary artery calcium (CAC) scoring. There were differences in the patient characteristics between the groups, with the USA patients being younger and having more diet and lifestyle-related risk factors, although hypertension may have been better controlled than in Europe. USA patients had a two-fold increase in prevalence of significant stenosis and a three-fold increase in median CAC score. In all three groups, the log CAC score proved to be the strongest predictor of >50% stenosis followed by male gender. In the USA group, there were no additional independently predictive risk factors, although in northern Europe obesity, hypertension, smoking and hypercholesterolaemia remained predictive, with all risk factors other than hypertension proving to be predictive in the southern Europe group. Without the CAC score as a variable, male gender followed by diabetes were the most important predictors in all three regions, with hypertension also proving predictive in northern Europe.Conclusion: In symptomatic patients, the CAC score and male gender were the two most important predictors of significant stenosis in symptomatic patients in northern and southern Europe and the USA.","PeriodicalId":32119,"journal":{"name":"International Cardiovascular Forum Journal","volume":"os-9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87186907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Atriogenic Flow Across a Restrictive Subaortic VSD: a Sign of Stiff Left ventricle","authors":"M. Islam, G. Fernandes, Wei Li, M. Henein","doi":"10.17987/ICFJ.V13I0.482","DOIUrl":"https://doi.org/10.17987/ICFJ.V13I0.482","url":null,"abstract":"Atriogenic Lt-Rt shunt across a ventricular septal defect is an uncommon finding, but reflects a stiff left ventricular cavity with raised end-diastolic pressure. These findings explain the left atrial enlargement and supraventricular arrhythmia. Thus, those shunts should be considered as safety valves to release the raised left sided pressure into the low pressure right ventricle. ","PeriodicalId":32119,"journal":{"name":"International Cardiovascular Forum Journal","volume":"25 9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82695855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Authors’ Responsibilities and Ethical Publishing","authors":"L. Shewan, A. Coats, M. Henein","doi":"10.17987/ICFJ.V13I0.525","DOIUrl":"https://doi.org/10.17987/ICFJ.V13I0.525","url":null,"abstract":"The International Cardiovascular Forum Journal requires authors to abide by the following guidelines:Manuscript: The corresponding author declares that the manuscript has not been published and is not under consideration elsewhere.Authorship: The corresponding author takes full responsibility for the list of authors. Any modification to the author list including order and composition can only be approved by the Editor-in-Chief following signed agreement from all the authors listed on the original submission.Ethics: The corresponding author states that the material presented has been obtained with the approval of all appropriate animal and/or human ethics committee(s).Permissions: The corresponding author on behalf of all authors confirms whether explicit written consent to publish has been received from any people described, pictured, or recorded and that formal copyright clearance is obtained to publish any video or audio recordings.Registration of Clinical Trials: Prospective registration of any clinical trial in a publically accessible database is a requirement for later publication of such trials in ICFJ. In exceptional circumstance if the trial is not registered, or is registered retrospectively, the reasons for this must be given.Competing Interests: All authors must declare all relevant competing interests (financial, or non-financial, professional, or personal) and state all funding sources.Attribution: The corresponding author accepts full responsibility for the accurate citation and acknowledgement of any material reproduced from other publications including the author’s own prior work.It is incumbent upon the corresponding author to consult the Editor-in-Chief should there be any variance of the above. The Editor-in-Chief retains the right to retract any submission found to be in breach of the above guidelines. ","PeriodicalId":32119,"journal":{"name":"International Cardiovascular Forum Journal","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89135171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Complications of Acute Myocardial Infarction or Takotsubo Cardiomyopathy: from Intravascular Thrombus Formation to Disseminated Intravascular Coagulation","authors":"S. Peters, B. Götting","doi":"10.17987/icfj.v13i0.535","DOIUrl":"https://doi.org/10.17987/icfj.v13i0.535","url":null,"abstract":"Two cases of suggested takotsubo syndrome and severe complications have been described. It has been discussed whether these two cases are complications of acute myocardial infarction or suggested takotsubo syndrome.","PeriodicalId":32119,"journal":{"name":"International Cardiovascular Forum Journal","volume":"82 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75893615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. T. Wang, Matthew D. Haydock, J. Pemberton, T. Wang
{"title":"Meta-analysis of Mitral Valve Repair Versus Replacement for Mitral Valve Infective Endocarditis","authors":"M. T. Wang, Matthew D. Haydock, J. Pemberton, T. Wang","doi":"10.17987/icfj.v13i0.504","DOIUrl":"https://doi.org/10.17987/icfj.v13i0.504","url":null,"abstract":"Background: Mitral valve repair has superior results to replacement for severe degenerative mitral valve disease, however in the infective endocarditis setting, mixed results have been reported. We compared the outcomes of mitral valve repair and replacement for infective endocarditis in this meta-analysis.Methods: MEDLINE, Embase and Cochrane databases from 1 January 1980 to 31 December 2015 were searched for original studies. Two authors evaluated these studies for inclusion independently, then data were extracted and pooled.Results: A total of 3,976 papers was obtained from the search, 99 full-texts were reviewed, and 13 studies which included both mitral valve repair and replacement patients involving 8,130 patients were included for analyses. Pooled rates and odds ratio (95% confidence interval) for operative mortality of repair versus replacement were 3.7% vs 10.9%, 0.33 (0.26-0.41). Odds ratio for long term mortality at 1-year (n=4) was 0.31 (0.14-0.72), and at 5 years (n=8) was 0.42 (0.25-0.69). Peri-operative stroke rates and odds ratio (n=4) were 2.8% vs 3.8%, 0.75 (0.55-1.00). Five year recurrent endocarditis and redo-operations (n=6 for both) odds ratios were 0.39 (0.10-1.58) and 0.49 (0.12-2.02) respectively. Similar results were observed when one large study making up 85% of the meta-analysis cohort population was removed.Conclusion: Mitral valve repair is associated with reduction in mortality and stroke, and similar recurrent endocarditis and redo-operation rates compared to mitral valve replacement in mitral valve endocarditis. It is therefore preferred when feasible, similar to surgery for degenerative mitral valve disease.","PeriodicalId":32119,"journal":{"name":"International Cardiovascular Forum Journal","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88362514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Gastric Dysrhythmia Corrected by Dual Chamber Pacemaker Implantation","authors":"M. G. Kiuchi","doi":"10.17987/ICFJ.V13I0.492","DOIUrl":"https://doi.org/10.17987/ICFJ.V13I0.492","url":null,"abstract":"HighlightsNausea has been defined as an “unpleasant painless subjective feeling that one will imminently vomit”. While nausea and vomiting are often thought to exist on a temporal continuum, this is not always the case. There are situations when severe nausea may be present without emesis and less frequently, when emesis may be present without preceding nausea. The underlying mechanisms involved in nausea are complex and encompass psychological states, the central nervous system, autonomic nervous system, gastric dysrhythmias, and the endocrine system. We report a 92-year-old male patient with depression, hypothyroidism, and intermittent severe sinus dysfunction, causing nausea, vomiting, and fatigue, pre-syncope and low cerebral output. Dual chamber implantation was performed and 24 hours after the implantation of the device all the symptoms disappeared, the parameters of the pacemaker were stable, and the patient was discharged. At the 1st and the 3rd month after implantation the patient remained asymptomatic. Over-activity of autonomic outflow may be a determinant for overall nausea intensity, probably, may be a potential therapeutic target to be corrected, at least in part, by a dual chamber pacemaker implantation.","PeriodicalId":32119,"journal":{"name":"International Cardiovascular Forum Journal","volume":"69 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79234911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. Čelutkienė, A. Jakstaite, J. Badarienė, S. Solovjova, Ieva Slivovskaja, R. Navickas, Edita Kazėnaitė, E. Rinkūnienė, A. Čypienė, J. Misiūra, L. Ryliškytė, A. Laucevičius, A. Coats
{"title":"Detection of Early Heart Failure with Preserved Ejection Fraction (HFpEF) in Metabolic Syndrome Patients Detected as Part of a National Screening Programme in Middle Aged Subjects","authors":"J. Čelutkienė, A. Jakstaite, J. Badarienė, S. Solovjova, Ieva Slivovskaja, R. Navickas, Edita Kazėnaitė, E. Rinkūnienė, A. Čypienė, J. Misiūra, L. Ryliškytė, A. Laucevičius, A. Coats","doi":"10.17987/ICFJ.V13I0.550","DOIUrl":"https://doi.org/10.17987/ICFJ.V13I0.550","url":null,"abstract":"Aims: To investigate if community detected Metabolic Syndrome (MetS) is associated with the burden of incipient HFpEF in the community. Methods and Results: We prospectively studied 148 consecutive MetS patients identified from the Lithuanian High Cardiovascular Risk primary prevention programme and investigated them further for unknown HFpEF through cardiopulmonary stress testing as well as assessment of BNP levels and of arterial stiffness. Subjects with a peak VO2 value lower than 90% of predicted and/or BNP≥35 ng/l were categorized as having early phase HFpEF. For comparison of this early phase HFpEF with others already clinically diagnosed with HFpEF, patients with both established HFpEF and MetS were selected retrospectively from patients attending our cardiopulmonary stress testing laboratory (n=38). Two thirds of the screening programme-derived MetS population (n=96) demonstrated a reduced exercise capacity and/or an elevated BNP, indicating signs of early HFpEF. Both the clinically diagnosed HFpEF and the screening programme detected MetS group with early HFpEF demonstrated similarly decreased exercise tolerance evaluated by peak oxygen uptake (79.8 ± 22.1% vs 82.7 ± 14.0%, p>0.05). Analysis of arterial markers in the screening programme group revealed statistically significant differences of augmentation index values between groups with and without signs of early HFpEF (p=0.016).Conclusion: A considerable proportion of patients having MetS may be diagnosed with previously undetected early stage HFpEF. The use of objective parameters of exercise capacity and neurohormonal activation might be effectively used for the early detection of HFpEF. Also early HFpEF in this setting is found to be associated with increased arterial stiffness. ","PeriodicalId":32119,"journal":{"name":"International Cardiovascular Forum Journal","volume":"80 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85534677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Preservation Technology: Opening the Field to New Possibilities","authors":"P. Chhaya, R. Murray","doi":"10.1353/fmj.2018.0000","DOIUrl":"https://doi.org/10.1353/fmj.2018.0000","url":null,"abstract":"Abstract:In their introduction to the issue, Priya Chhaya and Reina Murray outline two distinct roles that technology plays in historic preservation: (1) documenting historic places and managing the resulting data and (2) telling the stories of old and historic places. Reflecting on a year of exploring tech in preservation, they also contemplate fundamental questions about its impact—most essentially, how can technology best help us do our work?","PeriodicalId":32119,"journal":{"name":"International Cardiovascular Forum Journal","volume":"34 1","pages":"3 - 4"},"PeriodicalIF":0.0,"publicationDate":"2018-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86894311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R. Tredinnick, E. Gill, Destinee Udelhoven, K. Ponto
{"title":"Virtual Reality as an Agent of Preservation","authors":"R. Tredinnick, E. Gill, Destinee Udelhoven, K. Ponto","doi":"10.1353/FMJ.2018.0003","DOIUrl":"https://doi.org/10.1353/FMJ.2018.0003","url":null,"abstract":"Abstract:Staff from the Wisconsin Institute for Discovery's Living Environments Laboratory and the Mount Horeb Area Historical Society describe their use of light detection and ranging (LiDAR) scanning and virtual reality (VR) technologies in preservation. After explaining the mechanisms behind LiDAR and VR and giving a brief history of both, the authors describe their own projects, which include 3-D models of Taliesin East and Wisconsin's Norway Building. Finally, they discuss the future of VR in preservation—its potential and its limitations.","PeriodicalId":32119,"journal":{"name":"International Cardiovascular Forum Journal","volume":"50 1","pages":"22 - 29"},"PeriodicalIF":0.0,"publicationDate":"2018-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73362743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}